BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15033571)

  • 21. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
    Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
    Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes.
    Crescenzo-Chaigne B; Barbezange C; van der Werf S
    Virol J; 2008 Oct; 5():132. PubMed ID: 18973655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.
    Da Costa B; Sausset A; Munier S; Ghounaris A; Naffakh N; Le Goffic R; Delmas B
    J Virol; 2015 Jun; 89(12):6376-90. PubMed ID: 25855727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide-mediated interference with influenza A virus polymerase.
    Ghanem A; Mayer D; Chase G; Tegge W; Frank R; Kochs G; García-Sastre A; Schwemmle M
    J Virol; 2007 Jul; 81(14):7801-4. PubMed ID: 17494067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and structural analysis of the ribonucleoprotein complexes of different human influenza virus strains.
    Schreier E; Schweiger B; Stompor S; Stompor B; Schulze P; Michel S
    Acta Virol; 1988 Jul; 32(4):289-95. PubMed ID: 2903632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cis-acting signals and trans-acting factors involved in influenza virus RNA synthesis.
    O'Neill RE; Palese P
    Infect Agents Dis; 1994; 3(2-3):77-84. PubMed ID: 7812658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Architecture of ribonucleoprotein complexes in influenza A virus particles.
    Noda T; Sagara H; Yen A; Takada A; Kida H; Cheng RH; Kawaoka Y
    Nature; 2006 Jan; 439(7075):490-2. PubMed ID: 16437116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligomerization of the influenza virus nucleoprotein: identification of positive and negative sequence elements.
    Elton D; Medcalf E; Bishop K; Digard P
    Virology; 1999 Jul; 260(1):190-200. PubMed ID: 10405371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza virus nucleoprotein interacts with influenza virus polymerase proteins.
    Biswas SK; Boutz PL; Nayak DP
    J Virol; 1998 Jul; 72(7):5493-501. PubMed ID: 9621005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Definition of the minimal viral components required for the initiation of unprimed RNA synthesis by influenza virus RNA polymerase.
    Lee MT; Bishop K; Medcalf L; Elton D; Digard P; Tiley L
    Nucleic Acids Res; 2002 Jan; 30(2):429-38. PubMed ID: 11788704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
    Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
    Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein.
    Mazur I; Anhlan D; Mitzner D; Wixler L; Schubert U; Ludwig S
    Cell Microbiol; 2008 May; 10(5):1140-52. PubMed ID: 18182088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and assembly of the influenza A virus ribonucleoprotein complex.
    Zheng W; Tao YJ
    FEBS Lett; 2013 Apr; 587(8):1206-14. PubMed ID: 23499938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular assembly of the influenza virus RNA polymerase: determination of the subunit-subunit contact sites.
    Toyoda T; Adyshev DM; Kobayashi M; Iwata A; Ishihama A
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2149-57. PubMed ID: 8811014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine mapping of the subunit binding sites of influenza virus RNA polymerase.
    Ohtsu Y; Honda Y; Sakata Y; Kato H; Toyoda T
    Microbiol Immunol; 2002; 46(3):167-75. PubMed ID: 12008925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA-dependent activation of primer RNA production by influenza virus polymerase: different regions of the same protein subunit constitute the two required RNA-binding sites.
    Li ML; Ramirez BC; Krug RM
    EMBO J; 1998 Oct; 17(19):5844-52. PubMed ID: 9755184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of influenza virus RNA polymerase and nucleoprotein of gene expression by antisense oligonucleotides.
    Hatta T; Nakagawa Y; Takai K; Nakada S; Yokota T; Takaku H
    Nucleic Acids Symp Ser; 1995; (34):129-30. PubMed ID: 8841586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the interaction of influenza virus polymerase complex with human cell factors.
    Jorba N; Juarez S; Torreira E; Gastaminza P; Zamarreño N; Albar JP; Ortín J
    Proteomics; 2008 May; 8(10):2077-88. PubMed ID: 18491320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular anatomy of influenza virus RNA polymerase.
    Honda A; Ishihama A
    Biol Chem; 1997 Jun; 378(6):483-8. PubMed ID: 9224927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of functional influenza virus A polymerase proteins and template from cloned cDNAS in recombinant vaccinia virus infected cells.
    Zhang H; Air GM
    Biochem Biophys Res Commun; 1994 Apr; 200(1):95-101. PubMed ID: 8166749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.